146 related articles for article (PubMed ID: 25384699)
1. Morbidity among long-term survivors after pancreatoduodenectomy for pancreatic adenocarcinoma.
Chen KT; Devarajan K; Hoffman JP
Ann Surg Oncol; 2015 Apr; 22(4):1185-9. PubMed ID: 25384699
[TBL] [Abstract][Full Text] [Related]
2. Does long-term survival exist in pancreatic adenocarcinoma?
Zijlstra M; Bernards N; de Hingh IH; van de Wouw AJ; Goey SH; Jacobs EM; Lemmens VE; Creemers GJ
Acta Oncol; 2016; 55(3):259-64. PubMed ID: 26559995
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
4. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
[TBL] [Abstract][Full Text] [Related]
6. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.
Strobel O; Hartwig W; Hackert T; Hinz U; Berens V; Grenacher L; Bergmann F; Debus J; Jäger D; Büchler M; Werner J
Ann Surg Oncol; 2013 Mar; 20(3):964-72. PubMed ID: 23233235
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.
Farnell MB; Pearson RK; Sarr MG; DiMagno EP; Burgart LJ; Dahl TR; Foster N; Sargent DJ;
Surgery; 2005 Oct; 138(4):618-28; discussion 628-30. PubMed ID: 16269290
[TBL] [Abstract][Full Text] [Related]
8. Justifying vein resection with pancreatoduodenectomy.
Barreto SG; Windsor JA
Lancet Oncol; 2016 Mar; 17(3):e118-e124. PubMed ID: 26972858
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of vascular resection in pancreaticoduodenectomy: single-surgeon experience.
Menon VG; Puri VC; Annamalai AA; Tuli R; Nissen NN
Am Surg; 2013 Oct; 79(10):1064-7. PubMed ID: 24160800
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
[TBL] [Abstract][Full Text] [Related]
11. [Multivisceral and extended resection in pancreatic cancer].
Trede M; Schwall G
Langenbecks Arch Chir Suppl Kongressbd; 1992; ():61-5. PubMed ID: 1362900
[TBL] [Abstract][Full Text] [Related]
12. Results of pancreatic resection associated with portal vein resection in an Australian tertiary care centre.
Iorgulescu DG; Ling S; Nikfarjam M; Fink MA; Jones R; Muralidharan V; Starkey G; Christophi C
ANZ J Surg; 2015 Apr; 85(4):270-3. PubMed ID: 24712309
[TBL] [Abstract][Full Text] [Related]
13. Has survival following pancreaticoduodenectomy for pancreas adenocarcinoma improved over time?
Salem AI; Alfi M; Winslow E; Cho CS; Weber SM
J Surg Oncol; 2015 Nov; 112(6):643-9. PubMed ID: 26388048
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis.
Schäfer M; Müllhaupt B; Clavien PA
Ann Surg; 2002 Aug; 236(2):137-48. PubMed ID: 12170018
[TBL] [Abstract][Full Text] [Related]
16. Extended pancreatoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity.
De Reuver PR; Mittal A; Neale M; Gill AJ; Samra JS
Surgery; 2015 Jul; 158(1):183-90. PubMed ID: 25920909
[TBL] [Abstract][Full Text] [Related]
17. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms.
Cloyd JM; Tran Cao HS; Petzel MQ; Denbo JW; Parker NH; Nogueras-González GM; Liles JS; Kim MP; Lee JE; Vauthey JN; Aloia TA; Fleming JB; Katz MH
J Surg Oncol; 2017 Feb; 115(2):144-150. PubMed ID: 27859270
[TBL] [Abstract][Full Text] [Related]
18. Does preoperative biliary drainage compromise the long-term survival of patients with pancreatic head carcinoma?
Murakami Y; Uemura K; Hashimoto Y; Kondo N; Nakagawa N; Sasaki H; Hatano N; Kohmo T; Sueda T
J Surg Oncol; 2015 Mar; 111(3):270-6. PubMed ID: 25266938
[TBL] [Abstract][Full Text] [Related]
19. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
Meriggi F; Gramigna P; Forni E
Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
[TBL] [Abstract][Full Text] [Related]
20. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
